Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol

Alzheimer's disease is characterized by progressive cerebral cholinergic neuronal degeneration. Radiotracer analogs of benzovesamicol, which bind with high affinity to the vesamicol receptor located on the uptake transporter of acetylcholine storage vesicles, may provide an in vivo marker of ch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1996-08, Vol.39 (17), p.3331-3342
Hauptverfasser: Jung, Yong-Woon, Frey, Kirk A, Mulholland, G. Keith, del Rosario, Renato, Sherman, Phillip S, Raffel, David M, Van Dort, Marcian E, Kuhl, David E, Gildersleeve, David L, Wieland, Donald M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3342
container_issue 17
container_start_page 3331
container_title Journal of medicinal chemistry
container_volume 39
creator Jung, Yong-Woon
Frey, Kirk A
Mulholland, G. Keith
del Rosario, Renato
Sherman, Phillip S
Raffel, David M
Van Dort, Marcian E
Kuhl, David E
Gildersleeve, David L
Wieland, Donald M
description Alzheimer's disease is characterized by progressive cerebral cholinergic neuronal degeneration. Radiotracer analogs of benzovesamicol, which bind with high affinity to the vesamicol receptor located on the uptake transporter of acetylcholine storage vesicles, may provide an in vivo marker of cholinergic neuronal integrity. Five positional isomers of racemic iodobenzovesamicol (4‘-, 5-, 6-, 7-, and 8-IBVM) were synthesized, exchange-labeled with iodine-125, and evaluated as possible in vivo markers for central cholinergic neurons. Only two isomers, 5-IBVM (5) and 6-IBVM (10), gave distribution patterns in mouse brain consistent with cholinergic innervation:  striatum ≫ hippocampus ≥ cortex > hypothalamus ≫ cerebellum. The 24-h tissue-to-cerebellum concentration ratios for 5-IBVM (5) were 3−4-fold higher for striatum, cortex, and hippocampus than the respective ratios for 6-IBVM (10). Neither 8-IBVM (16) nor 4‘-IBVM (17) exhibited selective retention in any of the brain regions examined. In the heart, only 5-IBVM (5) exhibited an atria-to-ventricles concentration ratio consistent with high peripheral cholinergic neuronal selectivity. The 7-IBVM (14) isomer exhibited an anomalous brain distribution pattern, marked by high and prolonged retention in the five brain regions, most notably the cerebellum. This isomer was screened for binding in a series of 26 different biological assays; 7-IBVM (14) exhibited affinity only for the σ-receptor with an IC50 of ∼30 nM. Drug-blocking studies suggested that brain retention of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors. Competitive binding studies using rat cortical homogenates gave IC50 values for binding to the vesamicol receptor of 2.5 nM for 5-IBVM (5), 4.8 nM for 6-IBVM (10), and 3.5 nM for 7-IBVM (14). Ex vivo autoradiography of rat brain after injection of (−)-5-[125I]IBVM ((−)-[125I]5) clearly delineated small cholinergic-rich areas such as basolateral amygdala, interpeduncular nucleus, and facial nuclei. Except for cortex, regional brain levels of (−)-5-[123I]IBVM ((−)-[123I]5) at 4 h exhibited a linear correlation (r = 0.99) with endogenous levels of choline acetyltransferase. Conclusion:  Vesamicol receptor mapping of cholinergic nerve terminals in murine brain can be achieved with 5-IBVM (5) and less robustly with 6-IBVM (10), whereas the brain localization of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors.
doi_str_mv 10.1021/jm9507486
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78264566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15682844</sourcerecordid><originalsourceid>FETCH-LOGICAL-a410t-d24b53407c2854c39a54286856289eb800f52acf0143b606d9e6433648dcb4163</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EKtvCgR-A5AMgcQiMP-M9wopCpQWqsiDExXIcp_WSxMGTlI9fT8oue0LiNIfn0TujeQl5wOAZA86eb7ulglIafYssmOJQSAPyNlkAcF5wzcVdcoy4BQDBuDgiR6bUSrFyQa4_BXRd9KmlF8GHYUyZvnXDEPtLmhr6MrvY09VVamMf8mX09F2YcuqRfo_jFb1wdUwx1TMs6NpVoQ01PU8Yx5h619IzTF3I-Ccp9L_S9d9l98idxrUY7u_nCfl4-mqzelOs378-W71YF04yGIuay0oJCaXnRkkvlk5JbrRRmptlqAxAo7jzDTApKg26XgYthdDS1L6STIsT8mSXO-T0bQo42i6iD23r-pAmtKXhWir9f5EpbbiRchaf7kSfE2IOjR1y7Fz-aRnYmzLsoYzZfbgPnaou1Adz__2ZP9pzh961TXa9j3jQBDNSMDVrxU6LOIYfB-zyV6tLUSq7Of9gvwjY8M-G2Zu1j3e-82i3acpzFfiP834D7VOrNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15682844</pqid></control><display><type>article</type><title>Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol</title><source>MEDLINE</source><source>ACS Publications</source><creator>Jung, Yong-Woon ; Frey, Kirk A ; Mulholland, G. Keith ; del Rosario, Renato ; Sherman, Phillip S ; Raffel, David M ; Van Dort, Marcian E ; Kuhl, David E ; Gildersleeve, David L ; Wieland, Donald M</creator><creatorcontrib>Jung, Yong-Woon ; Frey, Kirk A ; Mulholland, G. Keith ; del Rosario, Renato ; Sherman, Phillip S ; Raffel, David M ; Van Dort, Marcian E ; Kuhl, David E ; Gildersleeve, David L ; Wieland, Donald M</creatorcontrib><description>Alzheimer's disease is characterized by progressive cerebral cholinergic neuronal degeneration. Radiotracer analogs of benzovesamicol, which bind with high affinity to the vesamicol receptor located on the uptake transporter of acetylcholine storage vesicles, may provide an in vivo marker of cholinergic neuronal integrity. Five positional isomers of racemic iodobenzovesamicol (4‘-, 5-, 6-, 7-, and 8-IBVM) were synthesized, exchange-labeled with iodine-125, and evaluated as possible in vivo markers for central cholinergic neurons. Only two isomers, 5-IBVM (5) and 6-IBVM (10), gave distribution patterns in mouse brain consistent with cholinergic innervation:  striatum ≫ hippocampus ≥ cortex &gt; hypothalamus ≫ cerebellum. The 24-h tissue-to-cerebellum concentration ratios for 5-IBVM (5) were 3−4-fold higher for striatum, cortex, and hippocampus than the respective ratios for 6-IBVM (10). Neither 8-IBVM (16) nor 4‘-IBVM (17) exhibited selective retention in any of the brain regions examined. In the heart, only 5-IBVM (5) exhibited an atria-to-ventricles concentration ratio consistent with high peripheral cholinergic neuronal selectivity. The 7-IBVM (14) isomer exhibited an anomalous brain distribution pattern, marked by high and prolonged retention in the five brain regions, most notably the cerebellum. This isomer was screened for binding in a series of 26 different biological assays; 7-IBVM (14) exhibited affinity only for the σ-receptor with an IC50 of ∼30 nM. Drug-blocking studies suggested that brain retention of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors. Competitive binding studies using rat cortical homogenates gave IC50 values for binding to the vesamicol receptor of 2.5 nM for 5-IBVM (5), 4.8 nM for 6-IBVM (10), and 3.5 nM for 7-IBVM (14). Ex vivo autoradiography of rat brain after injection of (−)-5-[125I]IBVM ((−)-[125I]5) clearly delineated small cholinergic-rich areas such as basolateral amygdala, interpeduncular nucleus, and facial nuclei. Except for cortex, regional brain levels of (−)-5-[123I]IBVM ((−)-[123I]5) at 4 h exhibited a linear correlation (r = 0.99) with endogenous levels of choline acetyltransferase. Conclusion:  Vesamicol receptor mapping of cholinergic nerve terminals in murine brain can be achieved with 5-IBVM (5) and less robustly with 6-IBVM (10), whereas the brain localization of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm9507486</identifier><identifier>PMID: 8765517</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Alzheimer Disease - pathology ; Alzheimer Disease - physiopathology ; Animals ; Autoradiography ; Binding, Competitive ; Biological and medical sciences ; Brain - cytology ; Brain - metabolism ; Brain - physiology ; Brain Mapping ; Cholinergic system ; Female ; Guinea Pigs ; Humans ; Iodine Radioisotopes ; Isomerism ; Medical sciences ; Mice ; Mice, Inbred Strains ; Neuromuscular Depolarizing Agents - chemical synthesis ; Neuromuscular Depolarizing Agents - metabolism ; Neurons - cytology ; Neurons - metabolism ; Neurons - physiology ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Organ Specificity ; Pharmacology. Drug treatments ; Piperidines - chemical synthesis ; Piperidines - metabolism ; Rats ; Rats, Sprague-Dawley ; Receptors, Cholinergic - analysis ; Tetrahydronaphthalenes - chemical synthesis ; Tetrahydronaphthalenes - metabolism</subject><ispartof>Journal of medicinal chemistry, 1996-08, Vol.39 (17), p.3331-3342</ispartof><rights>Copyright © 1996 American Chemical Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a410t-d24b53407c2854c39a54286856289eb800f52acf0143b606d9e6433648dcb4163</citedby><cites>FETCH-LOGICAL-a410t-d24b53407c2854c39a54286856289eb800f52acf0143b606d9e6433648dcb4163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm9507486$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm9507486$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2751,27055,27903,27904,56716,56766</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3184315$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8765517$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jung, Yong-Woon</creatorcontrib><creatorcontrib>Frey, Kirk A</creatorcontrib><creatorcontrib>Mulholland, G. Keith</creatorcontrib><creatorcontrib>del Rosario, Renato</creatorcontrib><creatorcontrib>Sherman, Phillip S</creatorcontrib><creatorcontrib>Raffel, David M</creatorcontrib><creatorcontrib>Van Dort, Marcian E</creatorcontrib><creatorcontrib>Kuhl, David E</creatorcontrib><creatorcontrib>Gildersleeve, David L</creatorcontrib><creatorcontrib>Wieland, Donald M</creatorcontrib><title>Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Alzheimer's disease is characterized by progressive cerebral cholinergic neuronal degeneration. Radiotracer analogs of benzovesamicol, which bind with high affinity to the vesamicol receptor located on the uptake transporter of acetylcholine storage vesicles, may provide an in vivo marker of cholinergic neuronal integrity. Five positional isomers of racemic iodobenzovesamicol (4‘-, 5-, 6-, 7-, and 8-IBVM) were synthesized, exchange-labeled with iodine-125, and evaluated as possible in vivo markers for central cholinergic neurons. Only two isomers, 5-IBVM (5) and 6-IBVM (10), gave distribution patterns in mouse brain consistent with cholinergic innervation:  striatum ≫ hippocampus ≥ cortex &gt; hypothalamus ≫ cerebellum. The 24-h tissue-to-cerebellum concentration ratios for 5-IBVM (5) were 3−4-fold higher for striatum, cortex, and hippocampus than the respective ratios for 6-IBVM (10). Neither 8-IBVM (16) nor 4‘-IBVM (17) exhibited selective retention in any of the brain regions examined. In the heart, only 5-IBVM (5) exhibited an atria-to-ventricles concentration ratio consistent with high peripheral cholinergic neuronal selectivity. The 7-IBVM (14) isomer exhibited an anomalous brain distribution pattern, marked by high and prolonged retention in the five brain regions, most notably the cerebellum. This isomer was screened for binding in a series of 26 different biological assays; 7-IBVM (14) exhibited affinity only for the σ-receptor with an IC50 of ∼30 nM. Drug-blocking studies suggested that brain retention of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors. Competitive binding studies using rat cortical homogenates gave IC50 values for binding to the vesamicol receptor of 2.5 nM for 5-IBVM (5), 4.8 nM for 6-IBVM (10), and 3.5 nM for 7-IBVM (14). Ex vivo autoradiography of rat brain after injection of (−)-5-[125I]IBVM ((−)-[125I]5) clearly delineated small cholinergic-rich areas such as basolateral amygdala, interpeduncular nucleus, and facial nuclei. Except for cortex, regional brain levels of (−)-5-[123I]IBVM ((−)-[123I]5) at 4 h exhibited a linear correlation (r = 0.99) with endogenous levels of choline acetyltransferase. Conclusion:  Vesamicol receptor mapping of cholinergic nerve terminals in murine brain can be achieved with 5-IBVM (5) and less robustly with 6-IBVM (10), whereas the brain localization of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors.</description><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer Disease - physiopathology</subject><subject>Animals</subject><subject>Autoradiography</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Brain - cytology</subject><subject>Brain - metabolism</subject><subject>Brain - physiology</subject><subject>Brain Mapping</subject><subject>Cholinergic system</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>Humans</subject><subject>Iodine Radioisotopes</subject><subject>Isomerism</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred Strains</subject><subject>Neuromuscular Depolarizing Agents - chemical synthesis</subject><subject>Neuromuscular Depolarizing Agents - metabolism</subject><subject>Neurons - cytology</subject><subject>Neurons - metabolism</subject><subject>Neurons - physiology</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Organ Specificity</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperidines - chemical synthesis</subject><subject>Piperidines - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Cholinergic - analysis</subject><subject>Tetrahydronaphthalenes - chemical synthesis</subject><subject>Tetrahydronaphthalenes - metabolism</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EKtvCgR-A5AMgcQiMP-M9wopCpQWqsiDExXIcp_WSxMGTlI9fT8oue0LiNIfn0TujeQl5wOAZA86eb7ulglIafYssmOJQSAPyNlkAcF5wzcVdcoy4BQDBuDgiR6bUSrFyQa4_BXRd9KmlF8GHYUyZvnXDEPtLmhr6MrvY09VVamMf8mX09F2YcuqRfo_jFb1wdUwx1TMs6NpVoQ01PU8Yx5h619IzTF3I-Ccp9L_S9d9l98idxrUY7u_nCfl4-mqzelOs378-W71YF04yGIuay0oJCaXnRkkvlk5JbrRRmptlqAxAo7jzDTApKg26XgYthdDS1L6STIsT8mSXO-T0bQo42i6iD23r-pAmtKXhWir9f5EpbbiRchaf7kSfE2IOjR1y7Fz-aRnYmzLsoYzZfbgPnaou1Adz__2ZP9pzh961TXa9j3jQBDNSMDVrxU6LOIYfB-zyV6tLUSq7Of9gvwjY8M-G2Zu1j3e-82i3acpzFfiP834D7VOrNA</recordid><startdate>19960816</startdate><enddate>19960816</enddate><creator>Jung, Yong-Woon</creator><creator>Frey, Kirk A</creator><creator>Mulholland, G. Keith</creator><creator>del Rosario, Renato</creator><creator>Sherman, Phillip S</creator><creator>Raffel, David M</creator><creator>Van Dort, Marcian E</creator><creator>Kuhl, David E</creator><creator>Gildersleeve, David L</creator><creator>Wieland, Donald M</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19960816</creationdate><title>Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol</title><author>Jung, Yong-Woon ; Frey, Kirk A ; Mulholland, G. Keith ; del Rosario, Renato ; Sherman, Phillip S ; Raffel, David M ; Van Dort, Marcian E ; Kuhl, David E ; Gildersleeve, David L ; Wieland, Donald M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a410t-d24b53407c2854c39a54286856289eb800f52acf0143b606d9e6433648dcb4163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer Disease - physiopathology</topic><topic>Animals</topic><topic>Autoradiography</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Brain - cytology</topic><topic>Brain - metabolism</topic><topic>Brain - physiology</topic><topic>Brain Mapping</topic><topic>Cholinergic system</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>Humans</topic><topic>Iodine Radioisotopes</topic><topic>Isomerism</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred Strains</topic><topic>Neuromuscular Depolarizing Agents - chemical synthesis</topic><topic>Neuromuscular Depolarizing Agents - metabolism</topic><topic>Neurons - cytology</topic><topic>Neurons - metabolism</topic><topic>Neurons - physiology</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Organ Specificity</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperidines - chemical synthesis</topic><topic>Piperidines - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Cholinergic - analysis</topic><topic>Tetrahydronaphthalenes - chemical synthesis</topic><topic>Tetrahydronaphthalenes - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jung, Yong-Woon</creatorcontrib><creatorcontrib>Frey, Kirk A</creatorcontrib><creatorcontrib>Mulholland, G. Keith</creatorcontrib><creatorcontrib>del Rosario, Renato</creatorcontrib><creatorcontrib>Sherman, Phillip S</creatorcontrib><creatorcontrib>Raffel, David M</creatorcontrib><creatorcontrib>Van Dort, Marcian E</creatorcontrib><creatorcontrib>Kuhl, David E</creatorcontrib><creatorcontrib>Gildersleeve, David L</creatorcontrib><creatorcontrib>Wieland, Donald M</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jung, Yong-Woon</au><au>Frey, Kirk A</au><au>Mulholland, G. Keith</au><au>del Rosario, Renato</au><au>Sherman, Phillip S</au><au>Raffel, David M</au><au>Van Dort, Marcian E</au><au>Kuhl, David E</au><au>Gildersleeve, David L</au><au>Wieland, Donald M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1996-08-16</date><risdate>1996</risdate><volume>39</volume><issue>17</issue><spage>3331</spage><epage>3342</epage><pages>3331-3342</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Alzheimer's disease is characterized by progressive cerebral cholinergic neuronal degeneration. Radiotracer analogs of benzovesamicol, which bind with high affinity to the vesamicol receptor located on the uptake transporter of acetylcholine storage vesicles, may provide an in vivo marker of cholinergic neuronal integrity. Five positional isomers of racemic iodobenzovesamicol (4‘-, 5-, 6-, 7-, and 8-IBVM) were synthesized, exchange-labeled with iodine-125, and evaluated as possible in vivo markers for central cholinergic neurons. Only two isomers, 5-IBVM (5) and 6-IBVM (10), gave distribution patterns in mouse brain consistent with cholinergic innervation:  striatum ≫ hippocampus ≥ cortex &gt; hypothalamus ≫ cerebellum. The 24-h tissue-to-cerebellum concentration ratios for 5-IBVM (5) were 3−4-fold higher for striatum, cortex, and hippocampus than the respective ratios for 6-IBVM (10). Neither 8-IBVM (16) nor 4‘-IBVM (17) exhibited selective retention in any of the brain regions examined. In the heart, only 5-IBVM (5) exhibited an atria-to-ventricles concentration ratio consistent with high peripheral cholinergic neuronal selectivity. The 7-IBVM (14) isomer exhibited an anomalous brain distribution pattern, marked by high and prolonged retention in the five brain regions, most notably the cerebellum. This isomer was screened for binding in a series of 26 different biological assays; 7-IBVM (14) exhibited affinity only for the σ-receptor with an IC50 of ∼30 nM. Drug-blocking studies suggested that brain retention of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors. Competitive binding studies using rat cortical homogenates gave IC50 values for binding to the vesamicol receptor of 2.5 nM for 5-IBVM (5), 4.8 nM for 6-IBVM (10), and 3.5 nM for 7-IBVM (14). Ex vivo autoradiography of rat brain after injection of (−)-5-[125I]IBVM ((−)-[125I]5) clearly delineated small cholinergic-rich areas such as basolateral amygdala, interpeduncular nucleus, and facial nuclei. Except for cortex, regional brain levels of (−)-5-[123I]IBVM ((−)-[123I]5) at 4 h exhibited a linear correlation (r = 0.99) with endogenous levels of choline acetyltransferase. Conclusion:  Vesamicol receptor mapping of cholinergic nerve terminals in murine brain can be achieved with 5-IBVM (5) and less robustly with 6-IBVM (10), whereas the brain localization of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>8765517</pmid><doi>10.1021/jm9507486</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1996-08, Vol.39 (17), p.3331-3342
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_78264566
source MEDLINE; ACS Publications
subjects Alzheimer Disease - pathology
Alzheimer Disease - physiopathology
Animals
Autoradiography
Binding, Competitive
Biological and medical sciences
Brain - cytology
Brain - metabolism
Brain - physiology
Brain Mapping
Cholinergic system
Female
Guinea Pigs
Humans
Iodine Radioisotopes
Isomerism
Medical sciences
Mice
Mice, Inbred Strains
Neuromuscular Depolarizing Agents - chemical synthesis
Neuromuscular Depolarizing Agents - metabolism
Neurons - cytology
Neurons - metabolism
Neurons - physiology
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Organ Specificity
Pharmacology. Drug treatments
Piperidines - chemical synthesis
Piperidines - metabolism
Rats
Rats, Sprague-Dawley
Receptors, Cholinergic - analysis
Tetrahydronaphthalenes - chemical synthesis
Tetrahydronaphthalenes - metabolism
title Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T04%3A36%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vesamicol%20Receptor%20Mapping%20of%20Brain%20Cholinergic%20Neurons%20with%20Radioiodine-%20Labeled%20Positional%20Isomers%20of%20Benzovesamicol&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Jung,%20Yong-Woon&rft.date=1996-08-16&rft.volume=39&rft.issue=17&rft.spage=3331&rft.epage=3342&rft.pages=3331-3342&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm9507486&rft_dat=%3Cproquest_cross%3E15682844%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15682844&rft_id=info:pmid/8765517&rfr_iscdi=true